K2M insider John P. Kostuik, MD, sold 46,957 shares of the company's stock in a transaction on June 18, according to a Mideast Times report.
Here are six quick facts:
1. The shares were sold at an average price of $24.56, for a total value of $1.15 million.
2. Dr. Kostuik now directly owns 190,114 shares in the company, valued at approximately $4.6 million.
3. Dr. Kostuik is a co-founder and CMO of K2M.
4. K2M has a one-year low of $12.31 and a one-year high of $26.29.
5. The stock has a 50-day moving average of $24 and a 200-day moving average of $21.
6. K2M's market cap is $995.34 million.